At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 34 enrolled
Drug / intervention
Tpoxxdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post Marketing Study of the Safety, Tolerability, and Pharmacokinetics of TPOXX In Adult Subjects Weighing More Than 120 KG
In Brief
A Phase 4 clinical trial evaluating Tpoxx for Smallpox. Completed, enrolled 34 participants across 1 site.
Detailed Summary
Safety and PK study in adults weighing more than 120 kg
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmallpox
CountriesUnited States
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
Enrollment StartJul 2019
Primary CompletionDec 2019
First PostedMay 2020
TodayJul 2026
First PostedMay 19, 2020
Enrollment StartJul 19, 2019
Primary CompletionDec 5, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.1 years ago
Interventions
Tpoxxdrug
oral antiviral